Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Recap of Tuesday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Relmada Therapeutics’ (NASDAQ:RLMD) lead asset REL-1017 as a monotherapy for the treatment major depressive disorder (MDD). Relmada shares traded in a range of $26.02 to $27.96 on a day volume of 173.79 thousand shares, closed regular trading…

Benzinga

Drugmaker Gilead to help fund monkeypox education for LGBTQ+ groups

Drugmaker Gilead Sciences plans to announce on Tuesday that it will provide up to $5 million in grants to help a coalition of LGBTQ+ and human rights advocacy groups craft public health responses to monkeypox outbreaks, the company said.

Reuters

Key leprosy drug shortage in India is not of recent origin

Pharmaceutical pricing authority discussed issue in 2019, show documents

The Hindu

From analysis to the latest developments in health,
read the most diverse news in one place.

France to launch pilot vaccination scheme against monkeypox

Four French pharmacies will be authorised to vaccinate against monkeypox from Wednesday, according to the office of Health Minister François Braun.

Radio France Internationale

Pfizer's Perth employees strike over pay

Pharmaceutical giant Pfizer is facing calls to improve its pay offer to manufacturing employees in Perth, who have walked off the job.

AAP

Trial seeks to develop first Lyme disease vaccine in 2 decades

The only Lyme disease vaccine previously marketed in the U.S. was discontinued in 2002.

Axios

2 Pharmaceutical Stocks That Could Outperform the Market in the Long Term

The pharmaceutical industry is growing rapidly with advancements in drug manufacturing and a paradigm shift to personalized medicines. Moreover, despite soaring prices, supportive fiscal policies are expected to keep consumer demand stable. Quality pharmaceutical stocks Pfizer (PFE) and Merck (MRK) have outperformed the broader market over the past year and…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Blackmores subsidiary kept selling pregnancy vitamins despite hundreds of complaints, ex-employee alleges

Whistleblower says he was instructed to tell customers the products were safe to consume, despite lack of testing evidence

The Guardian - AU

U.S. slams China's 'unacceptable' disruption in countering fentanyl

China's move to suspend cooperation with the United States to combat narcotics trafficking, including illicit fentanyl, is "unacceptable," the White House said on Monday, as Beijing continued to protest a visit to Taiwan by U.S. House Speaker Nancy Pelosi.

Reuters

BioNTech reports strong first half, expects demand to grow

BioNTech, which teamed with Pfizer to develop the first widely used COVID-19 vaccine, has reported higher revenue and net profit in the first half of the year

The Independent UK

Republicans condemned for striking down insulin cap in major Biden legislation: ‘Shame on you’

‘How many people have to die from insulin rationing before they stop blocking action?’

The Independent UK

LEXX: Put Your Drinks Up! Four Deals Signed in June

By John Vandermosten, CFA NASDAQ:LEXX READ THE FULL LEXX RESEARCH REPORT

Benzinga

East Bristol has lost most pharmacies in England since 2016

And there are concerns that more pharmacies could close soon

Bristol Post

Climate change puts Lyme disease in focus for France's Valneva after COVID blow

With climate change spurring more cases of tick-borne Lyme disease, drugmaker Valneva is betting big on a vaccine as it looks beyond disappointing sales of its COVID shot.

Reuters

Get all your
news in one place.

100’s of premium titles.
One news app.

Chicago Sun-Times

Another reason not to work in Indiana

Eli Lilly and Co. was quick to understand just how bad a near abortion ban can be on business.

Daily Mirror

Fears of 'chemist deserts' in areas where a third of pharmacies have shut in six years

New data reveals Bristol East, Bradford West, Pendle, Torbay and Hove are among the areas to have lost the largest numbers of pharmacies in the last few years

The Independent UK

COVID-19 vaccine sales push Moderna past expectations in Q2

Better-than-expected COVID-19 vaccine sales pushed Moderna past Wall Street’s second-quarter forecasts

The Guardian - UK

Haleon’s debut suggests it may not be the jewel in GSK’s medicine cabinet

Consumer goods spin-off makes few waves in biggest European listing for more than a decade

Get all your
news in one place.

100’s of premium titles.
One news app.

Al Jazeera

Africa CDC signs with Pfizer for COVID pill for African countries

Pfizer will now supply the COVID-19 pill that is highly effective in preventing hospitalisations and deaths.

The Independent UK

US allows pharmacists to prescribe Pfizer's COVID pill

U.S. pharmacists can now prescribe the leading COVID-19 pill directly to patients

The Guardian - AU

Pfizer vaccines that target Omicron variant pass first step to approval in Australia

The TGA’s ‘provisional determination’ for two vaccines comes as BA.4 and BA.5 subvariants drive new wave of Covid cases

Daily Record

Moderna confirms two-in-one Covid and flu jab in the works as testing under way

Scientists have developed an alternative to the current separate inoculations with the trial already under

Reuters

Novartis drug combo shows promise in childhood brain cancer

An oral drug combination by Swiss pharmaceuticals company Novartis showed promise in treating a subgroup of patients suffering from a common childhood brain cancer in a trial.

Tribune News Service

Biotech buyout: San Diego's Turning Point Therapeutics sells to Bristol Myers Squibb for $4.1 billion

Bristol Myers Squibb has inked a deal to buy San Diego's Turning Point Therapeutics for $4.1 billion in cash, strengthening the pharmaceutical giant's presence in precision cancer treatments.

The Independent UK

Tentative $161.5 million settlement reached in opioid trial

Attorneys for the state of West Virginia and two remaining pharmaceutical manufacturers have reached a tentative $161.5 million settlement

1 … 136 137 138 139

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.